Jurors imposed harsher penalties on corporate defendants in product-defect cases in 2009, according to data gathered by Bloomberg. The shift is seen as a reflection of overall public sentiment toward corporate America. "It's a reflection of the fact that Main Street is hurting," said plaintiffs' attorney Tobias Millrood, who won a $34-million verdict against Pfizer. "In this climate, there's a strong identification with the little man. Now a keener eye is given to the actions of Big Business."